CTL Medical has announced the executive management team that will lead the organisation into the next phase of its growth.
“We have a solid group of executives that we have brought into management roles,” said Daniel Chon, president and chief executive officer of CTL. “Our team consists of some of the best of the best in our business, and I am confident that they will help us further extend our position as a leader in the medical device design and manufacturing industry.”
Earlier this year, CTL acquired AccelSPINE, a medical device designer and manufacturer, as part of its global growth strategy. The company has now moved to a new 25,000-square foot facility “in order to better meet the needs of its customer base,” said a company press release.
CTL designs, develops and manufactures spinal implants and instruments tailored to fit the unique needs of surgeons and patients. Currently, the company has nine products: Degas Anterior Cervical Plate, Van Gogh Anterior Cervical Plate, Matisse ACIF Cage, Renoir Posterior Cervico-Thoracic Fixation, Picasso-II, MIS Spinal System, Raphael Pedicle Screw System, Cezanne TLIF Peek Cage (Curved), Cezanne-II TLIF Peek Cage (Bullet Tip) and Cezanne Disc Prep Set TLIF Disc Prep Instruments.
The following 11 leaders will comprise CTL’s executive management team: Danny Chon (president and chief executive officer), Fiona Lazarow (chief financial officer), Sean Suh (chief technology officer), Andy Choi (chief business development officer), Dean Fulford (vice president of sales for the northern region), Lanny Duyck (vice president of sales for the southern region), Jon Suh (vice president of research and development), Rose Moore (vice president of business development and marketing), Otis Blackwell (vice president of manufacturing), Sterling Thomason (director of operations), and Tosan Onosode (regulatory affairs specialist).
In addition to these appointments, a CTL press release states that it anticipates “a significant increase” in its workforce by early 2017.
